Remove tag digital-strategy
article thumbnail

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Rethinking Clinical Trials

The research yielded a report that provides 5 observations, 16 potential strategies, and more than 40 potential tactics for the FDA to consider. This work is important because the digital health information environment and limited public trust in government institutions represent pressing challenges for FDA.

article thumbnail

September 30, 2022: CTTI’s Digital Health Trials Hub Recommendations and Resources to Run Your Digital Health Trial (Marianne Chase, MGH, CTTI Team Lead, Jörg Goldhahn, ETH Zurich, CTTI Team Lead)

Rethinking Clinical Trials

Clinical Trial Transformation Initiative (CTTI); Decentralized Clinical Trials (DCTs); Digital endpoints; Developing novel endpoints. Digital Health Trials can help research obtain better and more reliable information, conduct more patient-centric research, and move at higher speed and efficiency. Key Points. Discussion Themes.

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insights from the 18th Annual Canadian Summit on Food Safety in 2024

XTalks

During a midday session, Anal Dave from Dessert Holdings and David Hatch, Vice President of Digital Solutions Marketing at Neogen , showcased their digital transformation strategies in environmental testing, enhancing detection and compliance. Xtalks speaking with Jud Sinton.

article thumbnail

Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA)

Rethinking Clinical Trials

We have continued to see the digital divide, where a small number of teams have expertise. Tags #pctGR, @Collaboratory1 The post Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA) appeared first on Rethinking Clinical Trials.

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. Analysing the world of digitally-native brands highlights three standout ways in which parts of their approach could be brought to the pharmaceutical world. Be more agile .

Branding 109
article thumbnail

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Rethinking Clinical Trials

Across 5 sessions, GGC4H offers strategies for promoting health and wellbeing, such as setting healthy and clear guidelines, positive discipline, dealing with anger constructively, resisting negative influences (with adolescents) and strengthening bonds and building life skills. 2) Can virtual GGC be delivered with fidelity?

article thumbnail

New to ELRIG Drug Discovery 2022: Tech Theatre supported by DDW

Drug Discovery World

Kanza will explain how we need to encourage people to digitise more, and we need better systems to manage the plethora of electronic data once it makes its way into digital form. Richmond is a mathematician with over 20 years’ experience of developing digital solutions to problems in drug discovery and development.

Drugs 52